| 000 | 02866cam a2200697 i 4500 | ||
|---|---|---|---|
| 001 | ocn893202845 | ||
| 003 | OCoLC | ||
| 005 | 20171026103952.0 | ||
| 006 | m o d | ||
| 007 | cr ||||||||||| | ||
| 008 | 141015s2015 nju ob 001 0 eng | ||
| 010 | _a 2014040927 | ||
| 020 |
_a9781118995280 _q(Adobe PDF) |
||
| 020 |
_a1118995287 _q(Adobe PDF) |
||
| 020 |
_a9781118996416 _q(ePub) |
||
| 020 |
_a1118996410 _q(ePub) |
||
| 020 | _a9781118995303 | ||
| 020 | _a1118995309 | ||
| 020 | _a9781322950167 | ||
| 020 | _a1322950164 | ||
| 020 |
_z9780470317617 _q(hardback) |
||
| 020 |
_z0470317612 _q(hardback) |
||
| 029 | 1 |
_aCHBIS _b010442421 |
|
| 029 | 1 |
_aCHVBK _b334093848 |
|
| 029 | 1 |
_aDEBBG _bBV042793948 |
|
| 029 | 1 |
_aGBVCP _b819918644 |
|
| 029 | 1 |
_aDEBBG _bBV043397209 |
|
| 035 |
_a(OCoLC)893202845 _z(OCoLC)961632602 _z(OCoLC)962630457 |
||
| 040 |
_aDLC _beng _erda _epn _cDLC _dN$T _dIDEBK _dDG1 _dRECBK _dSTF _dCOO _dCDX _dE7B _dYDXCP _dMMU _dOCLCF _dOCLCQ _dDEBBG _dEBLCP _dK6U |
||
| 042 | _apcc | ||
| 049 | _aMAIN | ||
| 050 | 0 | 0 | _aRM301.25 |
| 060 | 4 | _aQU 68 | |
| 072 | 7 |
_aMED _x071000 _2bisacsh |
|
| 082 | 0 | 0 |
_a615.1/9 _223 |
| 245 | 0 | 0 |
_aPeptide chemistry and drug design / _cedited by Ben M. Dunn. _h[electronic resource] |
| 264 | 1 |
_aHoboken, New Jersey : _bWiley, _c2015. |
|
| 300 | _a1 online resource | ||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aPeptide therapeutics -- Methods for the peptide synthesis and analysis -- Peptide design strategies for g-protein coupled receptors (GPCRs) -- Peptide-based inhibitors of enzymes -- Discovery of peptide drugs as enzyme inhibitors and activators -- Discovery of peptide drugs from natural sources -- Modification of peptides to limit metabolism -- Delivery of peptide drugs. | |
| 520 | _a"This book details many of the problems and successes of peptides as potential drugs"--Provided by publisher. | ||
| 588 | 0 | _aPrint version record and CIP data provided by publisher. | |
| 650 | 0 |
_aDrugs _xDesign. |
|
| 650 | 0 | _aPeptide drugs. | |
| 650 | 0 |
_aPeptides _xSynthesis. |
|
| 650 | 2 |
_aPeptides _xchemistry. |
|
| 650 | 2 | _aDrug Design. | |
| 650 | 2 | _aPharmaceutical Preparations. | |
| 650 | 7 |
_aMEDICAL _xPharmacology. _2bisacsh |
|
| 650 | 7 |
_aDrugs _xDesign. _2fast _0(OCoLC)fst00898790 |
|
| 650 | 7 |
_aPeptide drugs. _2fast _0(OCoLC)fst01057556 |
|
| 650 | 7 |
_aPeptides _xSynthesis. _2fast _0(OCoLC)fst01057580 |
|
| 655 | 4 | _aElectronic books. | |
| 700 | 1 |
_aDunn, Ben M., _eeditor. |
|
| 776 | 0 | 8 |
_iPrint version: _tPeptide chemistry and drug design. _dHoboken, New Jersey : Wiley, 2015 _z9780470317617 _w(DLC) 2014040280 |
| 856 | 4 | 0 |
_uhttp://onlinelibrary.wiley.com/book/10.1002/9781118995303 _zWiley Online Library |
| 942 |
_2ddc _cBK |
||
| 999 |
_c207712 _d207712 |
||